Literature DB >> 10965634

Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?

J D Edinger1, A I Fins, D M Glenn, R J Sullivan, L A Bastian, G R Marsh, D Dailey, T V Hope, M Young, E Shaw, D Vasilas.   

Abstract

Previous findings suggest that some who report insomnia sleep well, whereas some noncomplaining individuals sleep rather poorly. This study was conducted to determine if mood, anxiety, and sleep-related beliefs might relate to perceived sleep disturbance. Thirty-two women and 32 men (aged 40-79 years) with primary insomnia and an aged-matched sample of 61 normal sleepers (31 women, 30 men) completed 6 nocturnal sleep recordings, as well as the Beck Depression Inventory (BDI), the Trait portion of the State-Trait Anxiety Inventory (STAI-2), and the Dysfunctional Beliefs and Attitudes About Sleep Questionnaire. Sleep and interview data were used to subdivide the majority of the sample (n = 108) into objective normal sleepers and subjective insomnia sufferers who seemingly slept well and subjective normal sleepers and objective insomnia sufferers who slept poorly. The 2 subjective subgroups showed the most marked differences on most of the psychometric measures. The findings suggest that the psychological factors scrutinized in this study may mediate sleep satisfaction and/or predict objective sleep difficulties.

Entities:  

Mesh:

Year:  2000        PMID: 10965634

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  57 in total

1.  Sleep education for paradoxical insomnia.

Authors:  James D Geyer; Kenneth L Lichstein; Megan E Ruiter; L Charles Ward; Paul R Carney; Stephenie C Dillard
Journal:  Behav Sleep Med       Date:  2011       Impact factor: 2.964

2.  The ineffectiveness of magnotherapy in a patient with obstructive sleep apnea syndrome and cardiovascular comorbidity.

Authors:  Yaron Dagan; Katy Borodkin
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

3.  Treating insomnia.

Authors:  Anne M Holbrook
Journal:  BMJ       Date:  2004-11-20

4.  Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles.

Authors:  Julio Fernandez-Mendoza; Susan L Calhoun; Edward O Bixler; Maria Karataraki; Duanping Liao; Antonio Vela-Bueno; María Jose Ramos-Platon; Katherine A Sauder; Maria Basta; Alexandros N Vgontzas
Journal:  Psychosom Med       Date:  2010-10-26       Impact factor: 4.312

5.  Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 6.  Insomnia and its impact on physical and mental health.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

7.  Subjective and objective sleep difficulties in women with fibromyalgia syndrome.

Authors:  Alexa K Stuifbergen; Lorraine Phillips; Pat Carter; Janet Morrison; Ana Todd
Journal:  J Am Acad Nurse Pract       Date:  2010-09-03

8.  Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder?

Authors:  Louisa G Sylvia; Stephanie Salcedo; Amy T Peters; Pedro Vieira da Silva Magalhães; Ellen Frank; David J Miklowitz; Michael W Otto; Michael Berk; Andrew A Nierenberg; Thilo Deckersbach
Journal:  J Nerv Ment Dis       Date:  2017-03       Impact factor: 2.254

9.  Intraindividual sleep variability and its association with insomnia identity and poor sleep.

Authors:  Hylton E Molzof; Sarah E Emert; Joshua Tutek; Mazheruddin M Mulla; Kenneth L Lichstein; Daniel J Taylor; Brant W Riedel
Journal:  Sleep Med       Date:  2018-09-06       Impact factor: 3.492

10.  The impact of posttraumatic stress disorder on CPAP adherence in patients with obstructive sleep apnea.

Authors:  Jacob F Collen; Christopher J Lettieri; Monica Hoffman
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.